Co-morbidity in mild-to-moderate COPD: Comparison to normal and restrictive lung function

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 8, Issue 6, 2011, Pages 421-428

  Lindberg, Anne ^a,b   Larsson, Lars Gunnar ^b   Rönmark, Eva ^a,b   Lundbäck, Bo ^b,c  

^a UMEÅ UNIVERSITY   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cardiovascular disease; Chronic rhinitis; Co morbidity; COPD; Gastroesophageal reflux; Restrictive lung function

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RHINITIS; COMORBIDITY; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE;

BODY MASS INDEX; BRONCHITIS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHINITIS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SPIROMETRY; SWEDEN; VITAL CAPACITY;

EID: 83155183250     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.629858     Document Type: Article

References (27)

1. Mathers CD, Loncar D. Updated projections of global mortality and burden of disease, 2002-2030: data sources, methods and results. http://www.who.int/ healthinfo/statistics/bodprojections paper.pdf.
2. Jansson SA, Lindberg A, Ericsson A, Borg S, et al. Cost differences for COPD with and without physician-diagnosis. COPD 2005; 2(4):427-434. (Pubitemid 43879441)
3. Halbert RJ, Isonaka S, George D, et al. Interpreting COPDprevalence estimates. What is the true burden of disease? Chest 2003; 123:1684-1692. (Pubitemid 36549792)
4. Lundbäck B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD?-Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97(2):115-122. (Pubitemid 36284990)
5. Chatila WM, Thomashow BM, Minai OA, et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5:549-555. (Pubitemid 351669185)
6. Mannino DM,Thom D, Swensen A. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32:962-969.
7. Lindberg A, Bjerg A, Rönmark E, et al. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006; 100(2):264-272. (Pubitemid 43078978)
8. Siafakas NM, Vermeire P, Pride NB, et al. ERS Consensus Statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8:1398-1420.
9. Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28:1245-1257. (Pubitemid 44883863)
10. Annesi I, Kauffmann F. Is respiratorymucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. Am Rev Respir Dis 1986; 134(4):688-693. (Pubitemid 16008628)
11. Lundbäck B, Eriksson B, Lindberg A, et al. A 20-year followup of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies. COPD 2009;6(4):263-271.
12. Hurst JR. Upper airway. 3: Sinonasal involvement in chronic obstructive pulmonary disease. Thorax 2010; 65:85-90.
13. www.goldcopd.com.
14. Lindberg A, Lundbäck B.TheOLINCOPD study. Design, the first year participation and mortality. Clin Respir J 2008; 2:64-71.
15. Lindberg A, Larsson LG, Rönmark E, et al. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. COPD 2007 Mar; 4(1):5-13. (Pubitemid 46348289)
16. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152(3):1107-1136.
17. Berglund E, Birath G, Bjure J, et al. Spirometric studies in normal subjects, Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963; 173:185-192.
18. Hurst JR, Vestbo J, Anzueto A, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363(12):1128-1138.
19. Mokhlesi B, Morris AL, Huang CF, et al. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest 2001 Apr;119(4):1043-1048. (Pubitemid 32679428)
20. Rascon Aguilar, Pamer M, Wludyka P, et al. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest 2006; 130:1096-1101. (Pubitemid 44583740)
21. Gan WQ, Man SF. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and meta-analysis. Thorax 2004; 59:574-580. (Pubitemid 38901515)
22. Brownlee IA, Aseeri A, Ward C, et al. From gastric aspiration to airway inflammation Monaldi Arch Chest Dis 2010 Jun; 73(2):54-63.
23. Guerra S, Sherrill D L, Venker C, et al. Morbidity and mortality associated with the restrictive spirometric pattern; a longitudinal study. Thorax 2010; 65:499-504.
24. Mannino DM, Buist A S, Petty TL, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study.Thorax 2003; 58:388-393. (Pubitemid 36560940)
25. Lampe F,WalkerM, LennonL, et al.Validityof a self-reportedhistory of doctor-diagnosed angina. J Clin Epidemiol 1999; 52:73-81.
26. Olofsson M, Edebro D, Boman K. Are elderly patients with suspected HF misdiagnosed? A Primary Health Care Center Study. Cardiology 2006; 107:226-232.
27. Okura Y, Urban L, Mahoney W, et al. Agreement between selfreport questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004; 57:1096-1103. (Pubitemid 39446649)